Trial record 1 of 985 for:    DUAL-2
Previous Study | Return to List | Next Study

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-2)

This study has been terminated.
(company decision)
Information provided by (Responsible Party):
Actelion Identifier:
First received: October 31, 2011
Last updated: April 29, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)